Key result
Antiplatelet therapy in geriatric facilities frequently continues by inertia without routine re-evaluation.
Supports routine re-evaluation of antiplatelet therapy in geriatric facilities; leaves open optimal deprescribing strategies and outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tsuda et al. (2026) studied this question. Antiplatelet therapy in a geriatric care facility is frequently continued by inertia, characterized by heterogeneous indications and an absence of routine re-evaluation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Geriatrics and gerontology international/Geriatrics & gerontology international